SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Vistagen estimates about $1 million in severance and termination costs

Vistagen Therapeutics estimated severance and termination costs of about $1 million in an SEC filing.

VTGN

Related stories